Skip to main content
SpringerLink
Log in

Pulmonary complications of cancer therapy

  • Original Article
  • Published:
Comprehensive Therapy

Abstract

The development of pulmonary disease as a result of cancer therapy is an increasingly recognized clinical problem. Chemotherapeutic drugs can induce an acute pneumonitis, pulmonary edema, and pulmonary fibrosis, as well as a variety of other pulmonary diseases in cancer patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Rosenow EC III, Myers JL, Swensen SJ, Pisani RJ. Drug-induced pulmonary disease: an update.Chest. 1992;102:239–250.

    Article  PubMed  Google Scholar 

  2. Haupt HM, Hutchins GM, Moore GW. Ara-C lung: noncardiogenic pulmonary edema complicating cytosine arabinoside therapy of leukemia.Am J Med. 1981;70:256–261.

    Article  PubMed  CAS  Google Scholar 

  3. Goldiner PL, Carlon GC, Cvitkovic E, Schweizer O, Howland WS. Factors influencing postoperative morbidity and mortality in patients treated with bleomycin.Br Med J. 1978;1:1664–1667.

    PubMed  CAS  Google Scholar 

  4. Gilson AJ, Sahn SA. Reactivation of bleomycin lung toxicity following oxygen administration.Chest. 1985;88:304–306.

    Article  PubMed  CAS  Google Scholar 

  5. Jones G, Mierins E, Karsh J. Methotrexate-induced asthma.Am Rev Respir Dis. 1991;143:179–181.

    PubMed  CAS  Google Scholar 

  6. Walden PAM, Mitchell-Heggs PF, Coppin C, et al. Pleurisy and methotrexate treatment.Br Med J. 1977;1:867.

    Google Scholar 

  7. Comis RL. Bleomycin pulmonary toxicity: current status and future directions.Semin Oncol. 1992;19:64–70.

    PubMed  CAS  Google Scholar 

  8. Kaplan E, Sklar C, Wilmott R, Michaels S, Ghavimi F. Pulmonary function in children treated for rhabdomyosarcoma.Med Pediatr Oncol. 1996;27:79–84.

    Article  PubMed  CAS  Google Scholar 

  9. Lewis BM, Izbicki R. Routine pulmonary function tests during bleomycin therapy.JAMA. 1980;243:347–351.

    Article  PubMed  CAS  Google Scholar 

  10. Phillips GL, Gay JW, Herzig GP, et al. Intensive 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), NSC #4366650 and cryopreserved autologous marrow transplantation for refractory cancer: a phase I-II study.Cancer. 1983;52:1792–1802.

    Article  PubMed  CAS  Google Scholar 

  11. O’Driscoll BR, Hasleton PS, Taylor PM, Poulter LW, Gattamani, HR, Woodcock AA. Active lung fibrosis up to 17 years after chemotherapy with carmustine (BCNU) in childhood.N Engl J Med. 1990;323:378–382.

    PubMed  CAS  Google Scholar 

  12. Cherniack RM, Abrams J, Kalica AR. Pulmonary disease associated with breast cancer therapy.Am J Respir Crit Care Med. 1994;150:1169–1173.

    PubMed  CAS  Google Scholar 

  13. Chang AY-C, Kuebler JP, Pandya KJ, Israel RH, Marshall BC, Tormey DC. Pulmonary toxicity induced by mitomycin C is highly responsive to glucocorticoids.Cancer. 1986;57:2285–2290.

    Article  PubMed  CAS  Google Scholar 

  14. Movas B, Raffin TA, Epstein AH, Link CJ. Pulmonary radiation injury.Chest. 1997;111:1061–1076.

    Article  Google Scholar 

  15. Monson JM, Stark P, Reilly JJ, Sugarbaker DJ, Strauss GM, Swanson SJ, et al. Clinical radiation pneumonitis and radiographic changes after thoracic radiation therapy for lung cancer.Cancer. 1998;82:842–850.

    Article  PubMed  CAS  Google Scholar 

  16. Van Haecke P, Vansteenkiste J, Paridaens R, Van der Schueren E, Demedts M. Chronic lymphocytic alveolitis with migrating pulmonary infiltrates after localized chest wall irradiation.Acta Clinica Belgica. 1998;53:39–43.

    PubMed  Google Scholar 

  17. Anscher MS, Kong FM, Andrews K, Clough R, Marks LB, Bentel G, et al. Plasma transforming growth factor beta as a predictor of radiation pneumonitis.Int J Radiat Oncol Biol Phys. 1998;41:1029–1035.

    PubMed  CAS  Google Scholar 

  18. Tarbell NJ, Thompson L, Mauch P. Thoracic irradiation in Hodgkin’s disease: disease control and long-term complications.Int J Radiat Oncol Biol Phys. 1990;18:275.

    PubMed  CAS  Google Scholar 

  19. McInerney DP, Bullimore J. Reactivation of radiation pneumonitis by adriamycin.Br J Radiol. 1977;50:224–227.

    Article  Google Scholar 

  20. Wilczynski SW, Erasmus JJ, Petros WP, Vredenburgh JJ, Folz RJ. Delayed pulmonary toxicity syndrome following high-dose chemotherapy and bone marrow transplantation for breast cancer.Am J Respir Crit Care Med. 1998;157:565–573.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medical Service Kansas City VAMC, USA

    Lewis J. Wesselius MD (Chief, Associate Professor of Medicine)

  2. University of Kansas School of Medicine, Kansas City, Mo

    Lewis J. Wesselius MD (Chief, Associate Professor of Medicine)

Authors
  1. Lewis J. Wesselius MD
    View author publications

    You can also search for this author in PubMed Google Scholar

About this article

Cite this article

Wesselius, L.J. Pulmonary complications of cancer therapy. Compr Ther 25, 272–277 (1999). https://doi.org/10.1007/BF02944269

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02944269

Keywords

Search

Navigation